Here is the situation in plain terms. Microsoft is down roughly 29% from its all-time high. Azure grew 40% last quarter. The stock trades near its lowest forward P/E since 2023. And on July 29, the company reports fiscal Q4 2026 earnings on the exact same day the Federal Reserve announces its rate decision and Meta drops its own numbers. It is one of the most compressed catalyst windows of the entire year.
That is not a coincidence. It is a pressure test.
The Alphabet shock set the tone. Google posted record revenue of $119.8 billion and 82% cloud growth in Q2, then raised full-year 2026 capex guidance to a range of $195 billion to $205 billion. Free cash flow went negative for the first time since the company went public. Alphabet stock fell roughly 7% the next session. Investors did not punish Alphabet for the revenue. They punished it for the spending trajectory.
Microsoft is walking into that exact conversation. The company has guided to roughly $190 billion in calendar year 2026 capex. Deutsche Bank is forecasting management will raise that figure for FY2027, with some estimates in the $200+ billion range. That would be the number that spooks the market. Analysts say capex guidance around the low-$200 billions would be expected and tolerable. Anything meaningfully above that is the real risk.
Slight tangent, but it matters: today, July 27, a separate headline hit the tape. A Chinese state-backed company reportedly began mass-producing a key piece of DUV lithography equipment, a category previously controlled by ASML. Nvidia dropped roughly 5%, AMD fell more than 8%, ASML dropped more than 7%. Apple surpassed Nvidia as the world’s most valuable public company as a result. That is the macro backdrop heading into the busiest earnings stretch of Q2.
What the market actually wants from MSFT on Wednesday is not hard to describe. Azure acceleration above 40% would show the infrastructure spend is converting. Microsoft’s AI business was already running at a $37 billion annual revenue run rate as of April, up 123% year over year. Copilot adoption is growing. The commercial backlog provides some structural cushion. The EPS beat itself is almost priced in. Analysts expect $4.24 in diluted EPS, and Microsoft has beaten estimates for four straight quarters.
The part people skip is this: Morgan Stanley currently holds a $600 price target on the stock, implying more than 50% upside from where it trades today near $381. The stock sits below its own EMA20, EMA50, and EMA200 simultaneously, a textbook bearish moving average stack. It is the weakest performer in the Magnificent Seven year-to-date while the broader S&P 500 has gained roughly 9% in the same window.
That gap between the business performance and the stock performance is the trade idea. Not a slam dunk. A question with a specific answer date.
Options Positioning Ahead of Wednesday
IV into the print is elevated across July 29 and July 30 expirations. The market is pricing an implied move of roughly 7% to 9% in either direction based on the at-the-money straddle structure heading into the report. That is unusually wide for a company this size, which reflects the genuine uncertainty around what FY2027 capex guidance will look like.
For traders expecting a disciplined capex number combined with Azure acceleration, a defined-risk call spread targeting the $400 to $420 range through August expiry captures the potential re-rating without requiring a full reversal of the year’s damage. Bull case depends entirely on whether management signals capex is proportional to Azure’s growth path rather than running ahead of it.
Bear case is simpler. If FY2027 capex guidance comes in much higher than expectations and Azure growth prints below 40%, the stock tests the April-to-June area lows near $349. There is not much technical support between $380 and there.
Neutral case: defined-risk iron condor on both sides if you believe the report lands in line but the macro noise from the Fed decision and Meta earnings the same day creates enough cross-current uncertainty to pin the stock near current levels through the week.
The Fed Layer Nobody Is Fully Pricing
The Federal Reserve meets July 28 to 29, with Chair Kevin Warsh holding a press conference at 2:30 PM ET on July 29. The current fed funds target range is 3.50% to 3.75%. Rate expectations are not a neutral backdrop: depending on the day, market-implied odds have fluctuated between a hold and a 25 bp hike for this meeting, with investors also watching September. A hawkish tone from Warsh on the same afternoon Microsoft reports could compress the multiple even on a strong beat.
That is the scenario worth preparing for. A good MSFT print, a hawkish Fed press conference, and a spooked Meta reaction all landing within a six-hour window on July 29. Any one of those would move the stock. All three together could easily produce a 10% intraday range.
About one-third of the S&P 500 is expected to report this week. S&P 500 earnings growth for Q2 is currently tracking at roughly 38% year over year, far above original estimates. The macro picture is strong. The question is whether the market can look past hyperscaler spending anxiety long enough to reward a genuine business.
MSFT at 20x forward earnings is trading below its own 10-year average valuation. Azure grew 40% last quarter. The AI business is approaching $40 billion in annualized revenue. The stock is down 29% from its high.
Something has to give. Wednesday night is when we find out which side was right.
- Report date: July 29, 2026, after market close
- Consensus revenue: $87.67 billion
- Consensus EPS: $4.24
- Azure growth last quarter: 40%
- FY2026 capex guidance: ~$190 billion (calendar year 2026)
- Key risk: FY2027 capex guidance materially above expectations
- Morgan Stanley price target: $600 (current ~$381)
- 52-week range: $349.20 to $555.45
- Same-day catalysts: Fed rate decision, Meta Q2 earnings
